Growth Metrics

Vanda Pharmaceuticals (VNDA) EBT Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 32.79%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 47.54%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -49.71%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 12.01%
7 Evaxion A 62.56 Bn 62.54 Bn - 20.92%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -1.05%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 48.67%
10 Vanda Pharmaceuticals 379.35 Mn 177.04 Mn 48.56 Mn -120.77%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -120.77%
Dec 31, 2025 -81.24%
Sep 30, 2025 -93.09%
Jun 30, 2025 -123.77%
Mar 31, 2025 -70.31%
Dec 31, 2024 -40.18%
Sep 30, 2024 -37.20%
Jun 30, 2024 -34.58%
Mar 31, 2024 -34.76%
Dec 31, 2023 -29.11%
Sep 30, 2023 -26.29%
Jun 30, 2023 -38.40%
Mar 31, 2023 64.54%
Dec 31, 2022 18.28%
Sep 30, 2022 -23.66%
Jun 30, 2022 -31.01%
Mar 31, 2022 -132.48%
Dec 31, 2021 -5.85%
Sep 30, 2021 13.86%
Jun 30, 2021 38.92%
Mar 31, 2021 50.42%
Dec 31, 2020 101.97%
Sep 30, 2020 56.81%
Jun 30, 2020 110.01%
Mar 31, 2020 29.32%
Dec 31, 2019 138.81%
Sep 30, 2019 212.61%
Jun 30, 2019 65.09%
Mar 31, 2019 63.48%
Dec 31, 2018 39.12%
Sep 30, 2018 40.29%
Jun 30, 2018 41.97%
Mar 31, 2018 31.96%
Dec 31, 2017 -26.52%
Sep 30, 2017 -46.22%
Jun 30, 2017 58.64%
Mar 31, 2017 34.01%
Dec 31, 2016 59.67%
Sep 30, 2016 56.92%
Jun 30, 2016 -10.93%
Mar 31, 2016 -39.84%
Dec 31, 2015 -39.80%
Sep 30, 2015 -21.45%
Jun 30, 2015 11.99%
Mar 31, 2015 -8.94%
Dec 31, 2014 141.00%
Sep 30, 2014 23.12%
Jun 30, 2014 -149.33%
Mar 31, 2014 -473.73%
Dec 31, 2013 -116.66%
Sep 30, 2013 -99.87%
Jun 30, 2013 -67.76%